← Leaderboards
Richard Yen
Fibroplate, Inc.
$2,878,986
Attributed
$2,878,986
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2019–24$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,878,986 · 5
By mechanism
R44$1,811,658 · 1
R43$1,067,328 · 4
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Biological Products”
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- Leonard Freedman · Leidos Biomedical Research, Inc.$244,265,472
- Lynn Briscoe · Leidos Biomedical Research, Inc.$109,349,836
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
Research focus
Biological ProductsFibrinogenBlood PlateletsAlbuminsNanosphereIntravenousSmall Business Innovation Research GrantSiteHealingWound HealingAnimal ModelBaseDoseLifeSkin UlcerHemostatic FunctionRadiationRattusCytokineInjectableCostPre-ClinicalAnimalsPreclinical Study
Grant awards (6)
Fibrinogen-coated albumin nanospheres for mitigation of irradiation-induced wound healing impairment in breast cancer patients.$386,470
R43 · FY2024 · CA · contact PI
A multivalent, easy-to-use product to mitigate and treat radiation exposure$877,876
R44 · FY2021 · AI · contact PI
A novel agent to manage thrombocytopenic patients with platelet transfusion refractoriness$253,688
R43 · FY2021 · HL · contact PI
Fibrinogen coated albumin spheres to accelerate bone healing in older adults.$246,634
R43 · FY2021 · AG · contact PI
A multivalent, easy-to-use product to mitigate and treat radiation exposure$933,782
R44 · FY2020 · AI · contact PI
A multivalent, easy-to-use product to mitigate and treat radiation exposure$180,536
R43 · FY2019 · AI · contact PI